APA (7th ed.) Citation

S, F., M, Z., M, Š., P, K., AH, S., & EI, L. (2026). Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care. CNS drugs, 40(6), 733. https://doi.org/10.1007/s40263-026-01291-y

Chicago Style (17th ed.) Citation

S, Frol, Zupan M, Šabovič M, Kermer P, Siddiqui AH, and Levy EI. "Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care." CNS Drugs 40, no. 6 (2026): 733. https://doi.org/10.1007/s40263-026-01291-y.

MLA (9th ed.) Citation

S, Frol, et al. "Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care." CNS Drugs, vol. 40, no. 6, 2026, p. 733, https://doi.org/10.1007/s40263-026-01291-y.